Sökning: id:"swepub:oai:DiVA.org:liu-134620" > Work productivity l...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04979naa a2200553 4500 | |
001 | oai:DiVA.org:liu-134620 | |
003 | SwePub | |
008 | 170221s2016 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:uu-280015 | |
009 | oai:prod.swepub.kib.ki.se:135021767 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1346202 URI |
024 | 7 | a https://doi.org/10.1007/s10198-015-0749-y2 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2800152 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1350217672 URI |
040 | a (SwePub)liud (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Banefelt, J.u Quantify Research, Sweden4 aut |
245 | 1 0 | a Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden |
264 | c 2015-11-25 | |
264 | 1 | b SPRINGER,c 2016 |
338 | a electronic2 rdacarrier | |
500 | a Funding Agencies|Amgen, Inc. | |
520 | a Objectives To estimate productivity loss and associated indirect costs in high-risk patients treated for hyperlipidemia who experience cardiovascular (CV) events. Methods Retrospective population-based cohort study conducted using Swedish medical records linked to national registers. Patients were included based on prescriptions of lipid-lowering therapy between 1 January 2006 and 31 December 2011 and followed until 31 December 2012 for identification of CV events and estimation of work productivity loss (sick leave and disability pension) and indirect costs. Patients were stratified into two cohorts based on CV risk level: history of major cardiovascular disease (CVD) and coronary heart disease (CHD) risk equivalent. Propensity score matching was applied to compare patients with new events (cases) to patients without new events (controls). The incremental effect of CV events was estimated using a difference-in-differences design, comparing productivity loss among cases and controls during the year before and the year after the cases event. Results The incremental effect on indirect costs was largest in the CHD risk equivalent cohort (n = 2946) at (sic)3119 (P value amp;lt;0.01). The corresponding figure in the major CVD history cohort (n = 4508) was (sic)2210 (P value amp;lt;0.01). There was substantial variation in productivity loss depending on the type of event. Transient ischemic attack and revascularization had no significant effect on indirect costs. Myocardial infarction ((sic)), unstable angina ((sic)) and, most notably, ischemic stroke ((sic)) yielded substantial incremental cost estimates (P values amp;lt;0.01). Conclusions Indirect costs related to work productivity losses of CV events are substantial in Swedish high-risk patients treated for hyperlipidemia and vary considerably by type of event. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
650 | 7 | a SAMHÄLLSVETENSKAPx Ekonomi och näringsliv0 (SwePub)5022 hsv//swe |
650 | 7 | a SOCIAL SCIENCESx Economics and Business0 (SwePub)5022 hsv//eng |
653 | a Cardiovascular disease; Hyperlipidemia; Indirect costs; Productivity | |
700 | 1 | a Hallberg, S.u Quantify Research, Sweden4 aut |
700 | 1 | a Fox, K. M.u Strateg Healthcare Solut LLC, MD USA4 aut |
700 | 1 | a Mesterton, J.u Karolinska Institutet4 aut |
700 | 1 | a Paoli, C. J.u Amgen Inc, CA 91320 USA4 aut |
700 | 1 | a Johansson, Gunnaru Uppsala universitet,Allmänmedicin och preventivmedicin,Uppsala University, Sweden4 aut0 (Swepub:uu)gunnarjs |
700 | 1 | a Levin, Lars-Åkeu Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Medicinska fakulteten4 aut0 (Swepub:liu)larle77 |
700 | 1 | a Sobocki, P.u Karolinska Institute, Sweden; IMS Heatlh, Sweden4 aut |
700 | 1 | a Gandra, S. R.u Amgen Inc, CA 91320 USA4 aut |
710 | 2 | a Quantify Research, Swedenb Strateg Healthcare Solut LLC, MD USA4 org |
773 | 0 | t European Journal of Health Economicsd : SPRINGERg 17:9, s. 1117-1124q 17:9<1117-1124x 1618-7598x 1618-7601 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1075937/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://link.springer.com/content/pdf/10.1007/s10198-015-0749-y.pdf |
856 | 4 | u https://doi.org/10.1007/s10198-015-0749-yy Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:909492/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-134620 |
856 | 4 8 | u https://doi.org/10.1007/s10198-015-0749-y |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-280015 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:135021767 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.